EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development and Evaluation of a Population Pharmacokinetic Model for High‐Dose Methotrexate in Japanese Pediatric Patients with Acute Lymphoblastic Leukemia

Takuya Suzuoka, Tsubura Noda, Kota Tsuge, Yasuyoshi Ishiwata, Toshinori Hirai iD, Takeshi Isoda iD, Masatoshi Takagi iD, Masashi Nagata iD

The Journal of Clinical Pharmacology · 2026-10 · 66 (10)

DOI: 10.1002/jcph.70310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 12.10.2026. Verfasst von Takuya Suzuoka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Institute of Science Tokyo Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Antimetabolites, Antineoplastic, Methotrexate, Models, Biological, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methotrexate is a key chemotherapeutic agent for treating pediatric acute lymphoblastic leukemia (ALL); however, its pharmacokinetics exhibit substantial inter‐individual variability. Population pharmacokinetic (PPK) models have identified body weight and renal function as major determinants of methotrexate clearance. Nonetheless, the optimal PPK model for Japanese pediatric patients, considering hydration status, has not yet been established. This study aimed to develop a PPK model of high‐dose methotrexate specifically for Japanese pediatric patients with ALL. A retrospective PPK analysis was performed in pediatric patients with ALL, who were treated with high‐dose methotrexate at the Tokyo Medical and Dental University Hospital. Data from 38 patients (504 methotrexate concentrations; 27 for model development and 11 for validation) were analyzed using a two‐compartment model in NONMEM. Predictive performances of the newly developed and previously published models were assessed using the validation dataset. In the final model, clearance was described as a function of body surface area and hydration volume rate per body surface area (HYDR), whereas intercompartmental clearance was associated with age and HYDR. Evaluation using the validation dataset showed that the developed model had the best predictive performance among the evaluated models (median prediction error, 1.79%; median absolute prediction error, 13.3%; percentage of predictions with an absolute prediction error ≤20%, 70.3%; percentage of predictions with an absolute prediction error ≤30%, 82.9%). Simulation revealed modestly improved target‐attainment rates at relatively high hydration rates. These findings highlight the importance of fluid management and support the incorporation of hydration parameters into individualized high‐dose methotrexate therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimetabolites, AntineoplasticMethotrexateModels, BiologicalPrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentChildChild, PreschoolFemaleHumansInfantMaleBody Surface AreaDose-Response Relationship, DrugJapanRetrospective StudiesEast Asian People

Stichwörter der Autor:innen

high‐dose methotrexatemethotrexatepediatric acute lymphoblastic leukemiapopulation pharmacokinetics

Substanzen

Antimetabolites, AntineoplasticMethotrexate

Autor:innen und Institutionen

  • Department of Pharmacy, Institute of Science Tokyo Hospital, Tokyo, Japan.
  • Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.

ORCID-Profile: Toshinori Hirai, Takeshi Isoda, Masatoshi Takagi, Masashi Nagata

Förderung

  • JSPS KAKENHI

Zitieren

APA

Suzuoka, T., Noda, T., Tsuge, K., Ishiwata, Y., Hirai, T., Isoda, T., Takagi, M., & Nagata, M. (2026). Development and Evaluation of a Population Pharmacokinetic Model for High‐Dose Methotrexate in Japanese Pediatric Patients with Acute Lymphoblastic Leukemia. The Journal of Clinical Pharmacology, 66(10). https://doi.org/10.1002/jcph.70310

Vancouver

Suzuoka T, Noda T, Tsuge K, Ishiwata Y, Hirai T, Isoda T, et al. Development and Evaluation of a Population Pharmacokinetic Model for High‐Dose Methotrexate in Japanese Pediatric Patients with Acute Lymphoblastic Leukemia. The Journal of Clinical Pharmacology. 2026;66(10). doi:10.1002/jcph.70310

BibTeX
@article{Suzuoka2026,
  author = {Suzuoka, Takuya and Noda, Tsubura and Tsuge, Kota and Ishiwata, Yasuyoshi and Hirai, Toshinori and Isoda, Takeshi and Takagi, Masatoshi and Nagata, Masashi},
  title = {Development and Evaluation of a Population Pharmacokinetic Model for High‐Dose Methotrexate in Japanese Pediatric Patients with Acute Lymphoblastic Leukemia},
  journal = {The Journal of Clinical Pharmacology},
  year = {2026},
  volume = {66},
  number = {10},
  doi = {10.1002/jcph.70310}
}
Kostenlos starten →